Cancer Diagnostics
Total Trials
9
As Lead Sponsor
7
As Collaborator
2
Total Enrollment
5,791
NCT02700659
The Cxbladder Monitoring Study
Phase: N/A
Role: Lead Sponsor
Start: Feb 4, 2013
Completion: Sep 23, 2016
NCT03673202
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
Role: Collaborator
Start: Nov 26, 2018
Completion: Nov 30, 2020
NCT03988309
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA
Start: Sep 11, 2019
Completion: Jul 24, 2024
NCT04943380
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Start: Nov 8, 2019
Completion: Dec 31, 2025
NCT05080998
Longitudinal Bladder Cancer Study for Tumour Recurrence
Start: Jun 8, 2022
Completion: Aug 31, 2026
NCT05349812
Detection of Disease in the Upper Tract
Start: Nov 30, 2022
Completion: Dec 31, 2023
NCT05646485
Bladder Cancer Screening Trial
Start: May 5, 2023
Completion: Apr 30, 2028
NCT05889195
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
Start: Nov 2, 2023
NCT06394869
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Start: Apr 29, 2025
Completion: Mar 31, 2027
Loading map...